HOMCY CHARLES J 4

What Happened

• Charles J. Homcy, a director of Maze Therapeutics (MAZE), reported gifting 7,422 shares on 2026-05-04. The transaction is reported as a gift (transaction code G) with $0 proceeds; the Form 4 lists the shares as "disposed" for no consideration. The filing notes the gift is exempt under Rule 16b-5.

Key Details

• Transaction date: 2026-05-04; filing date: 2026-05-06 (appears timely).
• Price: $0.00 (gift); total proceeds reported: $0.
• Shares disposed: 7,422.
• Shares owned after transaction: not explicitly shown in the summary text provided here; the filing indicates the total in Table I (Column 5) includes shares previously held directly by the Charles J. Homcy Revocable Trust UA 11/4/1998 (see footnote).
• Footnotes: F1 — gift exempt under Rule 16b-5; F2 — Column 5 total includes shares from his revocable trust.

Context

• Gifts are transfers for no consideration and do not necessarily reflect the insider’s view of the company’s stock; they are commonly for estate or personal planning.
• This was a straight gift (not a sale, purchase, option exercise, or 10b5-1 plan transaction), and the Form 4 treats it as exempt under relevant insider-transaction rules.